Position in EW
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,985,597
+$649,062 QoQ
Shares Held
21,950
+31.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#470
of 1,315 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in EW Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GROUPAMA ASSET MANAGMENT holds $82,555,674 across 7 Medical Devices names. EW ranks #4 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
1,571,750 | $67,082,290 | |
| 2 | ABT |
Abbott Laboratories
|
85,053 | $7,717,709 | |
| 3 | MDT |
Medtronic plc
|
53,429 | $4,179,750 | |
| 4 | EW |
Edwards Lifesciences Corp
This page
|
21,950 | $1,985,597 | |
| 5 | PODD |
Insulet Corp
|
3,918 | $596,515 | |
| 6 | DXCM |
Dexcom Inc
|
7,973 | $536,981 | |
| 7 | SYK |
Stryker Corp
|
1,451 | $456,832 |
All Filings in EW
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,985,597 | 21,950 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,336,535 | 16,690 | Shares | Sole | 2026-05-22 | |
| 2025-09-30 | $1,337,877 | 17,203 | Shares | Sole | 2025-12-01 | |
| 2025-03-31 | $1,299,928 | 17,935 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,058,700 | 27,809 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,247,487 | 34,058 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $1,730,921 | 18,739 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,849,181 | 19,351 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,249,070 | 29,496 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||